CTIS2023-504630-22-00招募中1 期
MYTX-011-01
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Phase 1 dose-escalation trial of OMTX705, an anti-fibroblast activation protein antibody-drug conjugate, as single agent and in combination with pembrolizumab in patients with advanced solid tumorsSelected tumor indications that are known to express FAP (Fibroblast activation protein) either on tumor stroma CAFs (Cancer-associated fibroblasts) (carcinomas) or on tumor cells (leiomyosarcomas and other sarcomas).CTIS2024-514746-36-00Oncomatryx Biopharma S.L.120
招募中
1 期
A study of STX-721 in participants with non-small cell lung cancer with certain mutationsocally Advanced or Metastatic Non-Small Cell Lung CancerMedDRA version: 21.1Level: LLTClassification code: 10029514Term: Non-small cell lung cancer NOS Class: 10029104CTIS2023-506759-51-00Scorpion Therapeutics Inc.112
进行中（未招募）
1 期
A Randomised, Placebo-Controlled, Double-blind, Single and Multiple Ascending Dose, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Intravenous Administration of IRX-010 in Healthy ParticipantsInflammatory diseaseMedDRA version: 20.0Level: LLTClassification code: 10021426Term: Immune system disorder (NOS) Class: 10021428CTIS2023-503917-31-00Immunorx Pharma Inc.81
招募中
1 期
A study of STX-478 alone and in combination with other anticancer drugs in participants with advanced solid tumors.Advanced solid tumors including but not limited to gynecologic CancerHead and Neck Squamous Cell CarcinomaMedDRA version: 21.1Level: LLTClassification code: 10008229Term: Cervical cancer Class: 10029104MedDRA version: 21.0Level: PTClassification code: 10041823Term: Squamous cell carcinoma Class: 100000004864MedDRA version: 20.0Level: LLTClassification code: 10027475Term: Metastatic breast cancer Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10065252Term: Solid tumor Class: 10029104MedDRA version: 20.0Level: PTClassification code: 10033128Term: Ovarian cancer Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10014733Term: Endometrial cancer Class: 100000004864Breast CancerCTIS2023-504807-94-00Scorpion Therapeutics Inc.220
招募中
1 期
Testing for the first time the effects of a new medicine in healthy peoplePsychatric disorderCTIS2023-507880-20-00Eurofins Optimed72